Treatment of Headache in the ED
|
|
- Ella Ramsey
- 6 years ago
- Views:
Transcription
1 Treatment of Headache in the ED Benjamin W. Friedman, MD, MS, FAAEM Associate professor of Emergency Medicine Albert Einstein College of Medicine Montefiore Medical Center
2 Disclosure
3 Topics of Discussion 1) Why don t we use triptans in the ED (and should we?) 2) An ED specific nosology & the unobtainable goal of diagnostic clarity 3) Opioid wars: The frequent flyers
4 Why don t we use triptans in the ED Why don t we use triptans in the ED (and should we)?
5 Case 36y woman with typical headache x 18 hrs Started gradually at work yesterday Severe, occipital, bilateral, throbbing, with nausea. No relief with ibuprofen 800mg, naproxen 500mg, acetaminophen 1500mg, hydrocodone/ acetaminophen x 2 PMH: Migraine without aura; 3 previous ED visits for migraine Usually uses ibuprofen 2x/ month (with relief), PE: Unremarkable including normal cranial nerve exam, normal PE: Unremarkable including normal cranial nerve exam, normal visual acuity, and normal retinal exam
6 Treatment of migraine in US EDs Medication Any parenteral opioid 53% 51% Meperidine 7% 37% Hydromorphone 26% <1% Morphine 10% 1% Ketorolac 34% 16% Promethazine 33% 27% Metoclopramide 17% 3% Prochlorperazine 15% 16% Any triptan 7% 10% Dihydroergotamine 1% 3% Dexamethasone 8% 0% Friedman, West, Vinson, et.al. Cephalalgia. 2014
7 Why don t EPs use triptans? Content with current practice: what I use works Lack of exposure- Don t know/ don t trust Contra-indications- 39% of ED HA patients with elevated BP at triage 1 Unknown pregnancy status Unknown risk for coronary heart disease Demanding patients Fear of side effects 1. Gupta M. AHS June, 2005
8 Sumatriptan 2hr relief Drug, dose # of studies # improved with triptan # improved with placebo NNT Sumatriptan, 6mg, SQ 8 379/477 (79%) 131/461 (28%) 2.0 (1.8, 2.2) Oldman, Pain, 2002
9 All the triptans- 2hr headache relief Oldman, Pain, 2002
10 Efficacy of sumatriptan Subcutaneous sumatriptan, 6mg Meaningful relief Time to meaningful relief (median) Suma 75% 34 min 67% Placebo 35% NA 92% 24 hour recurrence (in those with relief) Adverse effects: 52% of Suma group (vs 27% of placebo). Dizziness, vertigo, paresthesias. 5 reported tdchest ttightness, heaviness, or numbness Akpunonu BE. Ann Emerg Med 1995;25(4):464 9
11 Metoclopramide versus Sumatriptan 6mg SQ MCP (n=40) Suma (n=38) Sumatriptan 6mg SQ Metoclopramide 20mgIV q 30m +DPH 2hr pain free 59% 36% Could resume normal activities 85% 69% Friedman, Neurology, 2005
12 Metoclopramide versus Sumatriptan 6mg SQ MCP 10mg IV Vs Sumatriptan (n=40) 60 min pain free: MCP: 65% Suma: 45% NNT=5 Esteban Morales 1999 MCP 20mg IV Vs Sumatriptan (n=124) MCP improves on average 1.1 more than Suma (0-10 scale) Talabi. Journal of Research in Medical Sciences. 2013
13 IV prochlorperazine 10mg + diphenhydramine 12.5mg Vs. Subcutaneous sumatriptan 6mg The mean decrease in pain intensity it in the IV prochlorperazine with diphenhydramine group was 73 mm compared with 50 mm in the subcutaneous sumatriptan group (difference=23 mm; 95% CI 11 to 36 mm). Kostic, A Emerg Med, 2010
14 Droperidol Droperidol 2.75mg IM Droperidol 8.25mg IM Droperidol 5.5mg IM Droperidol 0.1mg IM Placebo Silberstein., Neurology,
15 Haloperidol 5mg IV versus placebo Includes those who did not respond to n=20 n=20 n=24 placebo and others who did not consent for RCT
16 Chlorpromazine 0.1 mg/kg g vs placebo Migraine without aura Placebo n=30 Chlorpromazine n=30 Migraine with aura Placebo n=30 Pain Free at 30 3% 21% 0 37% minutes Chlorpromazine n=30 Pain Free at 60 10% 63% 7% 67% minutes Pain free at 24 hours 47% 74% 73% 90% Bigal, Journal of EM, 2002
17 Treatment of migraine: anti-dopaminergics Underappreciated/ underutilized for migraine Extensive clinical evidence base for these medications as primary treatment of migraine (mostly parenteral). Clinical data has outpaced basic science
18 Anti-histamines? Sustained relief (48 hours) Diphenhydramine Placebo Difference (95%CI) 41/99 39/103 4% (41%) (38%) ( 10, 17%)
19 Adverse events AE Diphenhydramine h Placebo Difference (95%CI) Very restless 8/99 7/102 1% (8%) (7%) ( 6, 8%) More Benadryl 6/104 (6%) 8/ 103 (8%) 2% ( 5, 9%)
20 Dexamethasone Colman. BMJ. 2008
21 AHS: Management of Adults with Acute Migraine in the Emergency Department Intravenous metoclopramide and prochlorperazine, and subcutaneous sumatriptan should be offered to eligible adults who present to an ED with acute migraine (Should offer Level B) Dexamethasone should be offered to these patients to prevent recurrence of headache (Should offer Level B) Because of lack of evidence demonstrating efficacy and concern about sub-acute or long-term sequelae, injectable morphine and hydromorphone are best avoided as first-line therapy (May avoid--level C)
22 Case 36y woman with typical headache x 18 hrs Started gradually at work yesterday Severe, occipital, bilateral, throbbing, with nausea. No relief with ibuprofen 800mg, naproxen 500mg, sumatriptan 100mg x 2 Akathisia after previous treatment with metoclopramide PMH: Migraine without aura; 3 previous ED visits for migraine Usually uses ibuprofen 2x/ month (with relief) PE: Unremarkable including normal cranial nerve exam, normal visual acuity, and normal retinal exam
23 How I treat migraine 1. Metoclopramide 2. Dexamethasone 3. Metoclopramide + ketorolac 4. Metoclopramide + DHE 5. GONB 6. Percocet? MOH? Chronic migraine? Psychiatric co-morbidities
24 An ED specific nosology & the unobtainable An ED specific nosology & the unobtainable goal of diagnostic clarity
25 How should I treat this patient? 36 year female presents with acute exacerbation of recurrent headache disorder x 12 hours. Similar to previous. Never been given a specific diagnosis. No relief with Advil 600mg 12 hours ago. RoS otherwise negative. Physical exam is noncontributory. Patient A -Left frontal -Throbbing -Associated with nausea Patient B -Bifrontal -Pressure/ tightness -Associated with nausea Patient C -Bifrontal -Pressure/ tightness -No associated symptoms
26 Diagnostic clarity Badness: Tumor, aneurysm, meningitis Migraine Tension-type headache Sinus headache Hypertensive headache
27 Diagnostic reality A cohort study of 480 patients Friedman, Hochberg, Esses, etal Annals Emergency Medicine 2007
28 Treatment of primary headaches Diagnosis Treatment Treatment Diagnosis
29 Metoclopramide 10mg IV Migraine (n=50) Tension-type (n=35) Improvement after 45 minutes 85% 81% Needed rescue medication 14% 14% Cicek M, Karcioglu O, Parlak I, et.al. EMJ, (3): 323-6
30 Sumatriptan 6mg SQ Migraine Tension-type (n=84) (n= 18) Baseline pain score (0-100) Improvement at 30 min 35% 38% Improvement at 60 min 57% 60% Miner, American Journal of Emergency Medicine, 2007
31 TTH Outcome Ketorolac Metoclopramide Difference 30mg IV 10mg (95%CI) Sustained freedom 9% 26% 17% (2, 32%) Friedman. Ann Emerg Med. 2013
32 TTH Medication Pain free 60 min Pain free 24 hours Chlorpromazine 0.1 mg/kg (n=30) 70% 87% Placebo (n=30) 20% 63% Bigal, Arq Neuropsiquiatr, 2002
33 How should I treat this patient? 36 year female Patient A -Left frontal -Throbbing -Associated with nausea Patient B -Bifrontal -Pressure/ tightness -Associated with nausea Patient C -Bifrontal -Pressure/ tightness -No associated symptoms Discuss differential diagnosis at time of discharge
34 Opioid wars & the Frequent Flyers
35 The case 36y woman, presents with her typical migraine headache 12 days of migraine/ month Sumatriptan and ibuprofen usually give relief 2 ED visits/ month for severe migraine refractory to oral treatment Presents with 10/10 severe pain for 6 hours Doc, just give me my Demerol
36 Opioids for treatment of headache in the ED The debate: Oligoanalgesia versus problematic behavior Oligoanalgesia: Underuse of analgesics in face of valid indication Problematic behavior: Drug-seeking and ED recidivism (inappropriate use of medical treatments and resources)
37 Reasons not to use opioids 1. Bouncebacks/ recidivism 2. Back to work 3. Chronification 4. Refractory to triptans Colman, Neurology, 2004; Bigal, Headache, 2008; Jakubowski, Headache, 2005; Ho, Headache, 2009
38 Therefore: 1. In opioid naïve patients: 2. In patients who request opioids: 3. In patients who insist on opioids: 4. In patients who frequently present to ED and insist on opioids:
39 Problematic patients Screen for interventions Outpatient provider Medication overuse headache Preventives Rule out secondary headache! Problematic patient committees Department wide policy/ Patient specific interventions to be implemented when the patient next returns to the ED Frequent visitor lists Treatment contracts
40 The case 36y woman, presents with her typical migraine headache 12 days of migraine/ month Sumatriptan and ibuprofen usually give relief 2 ED visits/ month for severe migraine refractory to oral treatment Presents with 10/10 severe pain for 6 hours Doc, just give me my Demerol
41
Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine
Acute Treatment Strategies in Adult & Pediatric Patients Theresa Mallick Searle, MS, RN BC, ANP BC Disclosures Speakers Bureau: Allergan, Depomed Acute Treatment Strategies in Adult & Pediatric Patients
More informationTreating Headache Recurrence After Emergency Department Discharge: A Randomized Controlled Trial of Naproxen Versus Sumatriptan
PAIN MANAGEMENT/ORIGINAL RESEARCH Treating Headache Recurrence After Emergency Department Discharge: A Randomized Controlled Trial of Naproxen Versus Sumatriptan Benjamin W. Friedman, MD, MS Clemencia
More informationInpatient Treatment of Refractory Headache
Inpatient Treatment of Refractory Headache MaryAnn Mays, MD Headache Center Center for Neurological Restoration Neurological Institute Cleveland Clinic Disclosures Speakers Bureau for Allergan, Teva, and
More informationISSN doi: /head VC 2015 American Headache Society Published by Wiley Periodicals, Inc.
ISSN 0017-8748 Headache doi: 10.1111/head.12746 VC 2015 American Headache Society Published by Wiley Periodicals, Inc. Review Article Acute Treatment Therapies for Pediatric Migraine: A Qualitative Systematic
More informationDose: Metoclopramide -0.1 mg/kg (max 10 mg) IV, over 15 minutes
Metoclopramide for Refractory Migraine in the ED Specific Care Question : In the pediatric patient diagnosed with refractory migraine, is metoclopramide an effective treatment? Question Originator: Migraine
More informationDisclosures. Triptans for Kids 5/16/13
5/16/13 Disclosures Triptans for Kids Amy A. Gelfand, MD GelfandA@neuropeds.ucsf.edu Departments of Neurology and Pediatrics UCSF Child Neurology and Headache Center I receive grant funding from: NIH/NINDS
More informationFaculty Disclosures. Learning Objectives. Acute Treatment Strategies
WWW.AMERICANHEADACHESOCIETY.ORG Acute Treatment Strategies Content developed by: Lawrence C. Newman, MD, FAHS Donna Gutterman, PharmD Faculty Disclosures LAWRENCE C. NEWMAN, MD, FAHS Dr. Newman has received
More informationPAIN MANAGEMENT AND SEDATION/ORIGINAL RESEARCH
PAIN MANAGEMENT AND SEDATION/ORIGINAL RESEARCH A Randomized Trial of Intravenous Ketorolac Versus Intravenous Metoclopramide Plus Diphenhydramine for Tension-Type and All Nonmigraine, Noncluster Recurrent
More informationComparison of Intravenous Metoclopramide and Acetaminophen in Primary Headaches: a Randomized Controlled Trial
1 Emergency (2015); 3 (*): ***-*** ORIGINAL RESEARCH Comparison of Intravenous Metoclopramide and Acetaminophen in Primary Headaches: a Randomized Controlled Trial Gholamreza Faridaalaee 1, Seyed Hesam
More informationWhat A Headache! Theresa Biesiada March 8, 2012
What A Headache! Theresa Biesiada March 8, 2012 Objectives Describe the EM relevance of headaches and migraines Discuss the rationale for steroid therapy Review the evidence Conclusions My inspiration
More informationSpecific Care Question : Question Originator: Plain Language Summary from The Office of Evidence Based Practice: Conditional Recommendation
Ketorolac for Refractory Migraine in the ED Specific Care Question : In the pediatric patient diagnosed with refractory migraine is ketorolac an effective treatment? Question Originator: Migraine Therapy
More informationThe best defense is a good offense. Optimizing the Acute Treatment of Migraine. Disclosures 11/10/2017
Optimizing the Acute Treatment of Migraine Brian M. Plato, DO, FAHS Norton Neuroscience Institute Louisville, KY Disclosures Speakers Bureau (personal): Allergan, Depomed, Avanir Research Funding (paid
More informationHow do we treat migraine? New SIGN Guidelines
How do we treat migraine? New SIGN Guidelines Managing your migraine Migraine Trust, Edinburgh 2018 Callum Duncan Consultant Neurologist Aberdeen Royal Infirmary Chair SIGN Guideline 155 Premonitory Mood
More informationTreatment Of Medication. Overuse Headache
7 November 2012 BASH GPwSI Meeting Lecture title... Treatment Of Medication Dr... Overuse Headache Dr Marcus Lewis Dr... The National Migraine Centre International Headache Society Diagnostic criteria
More informationChronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary
Chronic Migraine in Primary Care December 11 th, 2017 Werner J. Becker University of Calgary Disclosures Faculty: Werner J. Becker Relationships with commercial interests: Grants/Research Support: Clinical
More informationMIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.
MIGRAINE UPDATE Karen L. Bremer, MD November 16, 2018 Objectives & Disclosures Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment. Disclosure: I am
More informationHMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in
HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in Anesthesia and Neurology Harvard Medical School Limited time
More informationA synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN
A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline Scottish intercollegiate Guidelines Network SIGN November 2008. PETER FRAMPTON MSc MCOptom BAppSc (Optom)(AUS)
More informationMigraine Acute treatment
Migraine Acute treatment Elizabeth Loder, MD, MPH Professor of Neurology, Harvard Medical School Chief, Division of Headache, Department of Neurology, Brigham and Women s Hospital, Boston, MA Disclosures
More informationBuilding a Headache Infusion Program
Building a Headache Infusion Program Lauren Doyle Strauss, DO UCNS Board Certified Headache Specialist Headache Clinic Director Assistant Professor in Pediatric Neurology Associate Residency Director,
More informationClinical Learning Days November 10, 2017
Migraine Clinical Learning Days November 10, 2017 Alyssa Lettich. MD Neurosciences Institute/Neurosciences Clinical Program Medical Director Headache Disclosures: none Learning Objectives: At the conclusion
More informationHEADACHE: Benign or Severe Dr Gobinda Chandra Roy
HEADACHE: Benign or Severe Dr Gobinda Chandra Roy Associate Professor, Department of Medicine, Shaheed Suhrawardy Medical College and Hospital Outlines 1. Introduction 2. Classification of headache 3.
More informationMigraine is a common recurrent neurological disorder with
Review Article Department Part 1: Diagnosis, General Management, and Role of Dopamine Antagonists and NSAIDs Vongvaivanich K, MD Kiratikorn Vongvaivanich, MD 1 Keywords: treatment for migraine headache,
More informationParenteral Dihydroergotamine for Acute Migraine Headache: A Systematic Review of the Literature
NEUROLOGY/ORIGINAL RESEARCH Parenteral Dihydroergotamine for Acute Migraine Headache: A Systematic Review of the Literature Ian Colman, MSc Michael D. Brown, MD, MSc Grant D. Innes, MD Eric Grafstein,
More informationA case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:
Chronic Daily Headache Bassel F. Shneker, MD, MBA Associate Professor Vice Chair, OSU Neurology The Ohio State University Wexner Medical Center Financial Disclosures None related to the presentation Grants
More informationMIGRAINE A MYSTERY HEADACHE
MIGRAINE A MYSTERY HEADACHE The migraine is a chronic neurological disease that is characterized by moderate to severe episodes of headache that is mostly associated with other central nervous system (CNS)
More informationHEADACHE. Dr Nick Pendleton. September Headache
HEADACHE Dr Nick Pendleton September 2017 Headache Tension Type Headache Cranial Nerve Examination Migraine Migraine Treatment Medication Overuse Headache Headache Red Flags Sinusitis Headache Raised ICP
More informationInpatient Treatment of Status Migraine With Dihydroergotamine in Children and Adolescents
Headache 2008 the Authors Journal compilation 2008 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2008.01293.x Published by Wiley Periodicals, Inc. Brief Communication Inpatient Treatment
More informationHeadaches in Pregnancy Before, During, and After
Headaches in Pregnancy Before, During, and After Robert Kaniecki, MD Director, UPMC Headache Center Assistant Professor of Neurology University of Pittsburgh Headaches and Pregnancy Pre-pregnancy counseling
More informationI. Migraine management in the Emergency Department
Comer Children s Hospital Pediatric Guidelines Guideline: Migraine management in the ED Guideline #: PED-06 Section: Neurology Page: 1 of 10 Developed date: 11/17/2016 Revision date: none Review date:
More informationDrug Class Review Triptans
Drug Class Review Triptans April 2013 Last Report: Update #4 (June 2009) The purpose of reports is to make available information regarding the comparative clinical effectiveness and harms of different
More informationADVANCES IN MIGRAINE MANAGEMENT
ADVANCES IN MIGRAINE MANAGEMENT Joanna Girard Katzman, M.D.MSPH Assistant Professor, Dept. of Neurology Project ECHO, Chronic Pain Program University of New Mexico Outline Migraine throughout the decades
More information10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD
Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD } Depomed Consultant 2014 to present } Avanir Consultant 2014 to present } Amgen
More informationMEASURE #1: MEDICATION PRESCRIBED FOR ACUTE MIGRAINE ATTACK Headache
MEASURE #1: MEDICATION PRESCRIBED FOR ACUTE MIGRAINE ATTACK Headache Measure Description Percentage of patients age 12 years and older with a diagnosis of migraine who were prescribed a guideline recommended
More informationAbstract The aim of this prospective,
J Headache Pain (2005) 6:143 148 DOI 10.1007/s10194-005-0169-y ORIGINAL Zulfi Engindeniz Celaleddin Demircan Necdet Karli Erol Armagan Mehtap Bulut Tayfun Aydin Mehmet Zarifoglu Intramuscular tramadol
More informationH-A-L-D-O-L Spells Relief
No Relevant Financial Disclosures H-A-L-D-O-L Spells Relief Novel Pain Management Strategies Bill Soares MD, MS Assistant Professor of Emergency Medicine UMMS-Baystate Put another way Decreased opioid
More information10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67%
PRIMARY CARE AND HEADACHE Sonja Potrebic MD PhD Regional Headache Specialist Kaiser LAMC 1 WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Column1 Primary Care 67% Primary Care Headache Specialty Other
More information25/09/2018 HEADACHE. Dr Nick Pendleton
HEADACHE Dr Nick Pendleton September 2018 1 Small Group Work Tension Type Headache Cranial Nerve Examination Migraine Migraine Treatment Medication Overuse Headache Headache Red Flags Sinusitis Headache
More informationClinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.
OVERVIEW Refractory headaches and update on novel treatment Definition of refractory headache Treatment approach Medications Neuromodulation In the pipeline Juliette Preston, MD OHSU Headache Center Refractory
More informationIndex. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.
Prim Care Clin Office Pract 31 (2004) 441 447 Index Note: Page numbers of article titles are in boldface type. A Abscess, brain, headache in, 388 Acetaminophen for migraine, 406 407 headache from, 369
More informationChronic Daily Headaches
Chronic Daily Headaches ANWARUL HAQ, MD, MRCP(UK), FAHS DIRECTOR BAYLOR HEADACHE CENTER, DALLAS, TEXAS DISCLOSURES: None OBJECTIVES AT THE CONCLUSION OF THIS ACTIVITY, PARTICIPANTS WILL BE ABLE TO: define
More informationHeadache A Practical Approach
Headache A Practical Approach Integrated Pain Symposium December 1, 2017 Alyssa Lettich. MD Neurosciences Institute/Neurosciences Clinical Program Medical Director Headache and Pain Development Teams Disclosures:
More informationCOMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS
ACUTE THEAPIES TIPTANS TICYCLIC ANTIDEPESSANTS When starting acute treatment, healthcare professionals should warn patients about the risk of developing medication-overuse headache. ASPIIN Aspirin (900
More informationFaculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.
Faculty Disclosure Karen L. Bremer, MD Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest. HEADACHE UPDATE Karen L. Bremer, MD November 10, 2017 karen.bremer@creighton.edu
More informationShort Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment
Clinical Highlights 1. Headache is diagnosed by history and physical examination with limited need for imaging or laboratory tests. 2. Warning signs of possible disorder other than primary headache are:
More informationThe 45-year-old woman with monthly headaches. Anne MacGregor Barts and the London School of Medicine and Dentistry
The 45-year-old woman with monthly headaches Anne MacGregor Barts and the London School of Medicine and Dentistry Learning Objectives Use of diary cards for establishing patterns of attacks Importance
More informationWORRIED ABOUT PAIN AFTER ORAL SURGERY?
WORRIED ABOUT PAIN AFTER ORAL SURGERY? OPIOIDS ARE NOT THE ONLY WAY TO MANAGE PAIN Ask your doctor about opioid-free EXPAREL EXPAREL is indicated for single-dose infiltration in adults to produce postsurgical
More informationMEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache
MEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache Measure Description Percentage of patients age 18 years old and older with a diagnosis of primary headache
More informationHeadaches in the Pediatric Emergency Dept
Headaches in Children February 23, 2011 Jinny Tavee, MD Associate Professor Neuromuscular Center Cleveland Clinic Foundation Cleveland, OH 1 Headaches in the Pediatric Emergency Dept Burton Gutierrez Kan
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationI have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.
I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation. In 1962, Bille published landmark epidemiologic survey of headache among 9,000 school
More informationHeadache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches
Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, 2016 II. Management of Refractory Headaches Case presentation 1: A case of intractable daily-persistent headache Keio University School
More informationWhat You Should Know About Your HEADACHE. Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself
What You Should Know About Your HEADACHE Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself Introduction The purpose of this brochure is to give you a
More informationOptimizing Your Quality of Life During Cancer Treatment: Pain & Side Effect Management
Optimizing Your Quality of Life During Cancer Treatment: Pain & Side Effect Management Eric Roeland, MD GI Oncology Palliative Medicine Pancreatic Cancer Patient Tool Belt Chemotherapy Surgery Pain & Symptom
More informationLasmiditan (200 mg and 100 mg) Compared to Placebo for Acute Treatment of Migraine
(200 mg and 100 mg) Compared to for Acute Treatment of Migraine Bernice Kuca, M.S. 1 ; Linda A. Wietecha, B.S.N., M.S. 2 ; Paul H. Berg, M.S. 2 ; Sheena K. Aurora, M.D. 2 1 CoLucid Pharmaceuticals, Inc.,
More informationPAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose
NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,
More informationMaternity. Migraine in pregnancy Information for women
Maternity Migraine in pregnancy Information for women You have been given this leaflet as you have a diagnosis of migraines. It contains advice to help you manage your migraines safely during your pregnancy.
More informationPeri operative pain control. Disclosure. Objectives 9/1/2011. No current conflicts of interest
Peri operative pain control Chris Herndon, PharmD, FASHP Southern Illinois University Edwardsville Disclosure No current conflicts of interest Objectives Discuss studies evaluating the transformation of
More informationDrug Class Review Triptans
Drug Class Review Triptans Preliminary Update Scan #3 February 2014 Last Report: Update #4 (June 2009) The purpose of reports is to make available information regarding the comparative clinical effectiveness
More informationCONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY?
CONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY? ASK YOUR DOCTOR ABOUT EXPAREL FOR LONG-LASTING, NON-OPIOID PAIN RELIEF. VISIT EXPAREL.com/patient FOR MORE INFORMATION. YOU HAVE A SAY IN HOW YOUR PAIN IS
More informationDisclosures. Objectives 6/2/2017
Classification: Migraine and Trigeminal Autonomic Cephalalgias Lauren Doyle Strauss, DO, FAHS Assistant Professor, Child Neurology Assistant Director, Child Neurology Residency @StraussHeadache No disclosures
More informationGoals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders
Goals One-Year Prevalence of Common Headache Disorders Impact of primary headache syndromes Non pharmacologic Rx of migraine individualized to patient triggers Complementary and alternative Rx of migraine
More informationPrednisone vs. placebo in withdrawal therapy following medication overuse headache
doi:10.1111/j.1468-2982.2007.01488.x Prednisone vs. placebo in withdrawal therapy following medication overuse headache L Pageler 1,2, Z Katsarava 2, HC Diener 2 & V Limmroth 1,2 1 Department of Neurology,
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationHeadache evaluation and management after concussion. Assistant Professor
Headache evaluation and management after concussion Juliette Preston, M.D. Assistant Professor OHSU Headache Center OVERVIEW Introduction Definition Acute post-traumatic headache Red flags Persistent post-traumatic
More informationControversies in Migraine Management
Controversies in Migraine Management A Technology Assessment Draft Report June 13, 2014 Completed by: Institute for Clinical and Economic Review Institute for Clinical & Economic Review, 2014 AUTHORS:
More informationThe ALTO Program: A Strategy to Reduce Opioid use in the Emergency Department
The ALTO Program: A Strategy to Reduce Opioid use in the Emergency Department The ALTO Program: A Strategy to Reduce Opioid use in the Emergency Department Steven F. Nerenberg, Pharm.D. Clinical Assistant
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More information11. HEADACHE 1. Pablo Lapuerta, MD, Steven Asch, MD, MPH, and Kenneth Clark, MD, MPH
11. HEADACHE 1 Pablo Lapuerta, MD, Steven Asch, MD, MPH, and Kenneth Clark, MD, MPH We identified articles on the evaluation and management of headache by conducting a MEDLINE search of English language
More informationMeasure Components Numerator Statement
MEASURE #5: OVERUSE OF OPIOID CONTAINING MEDICATIONS FOR PRIMARY HEADACHE DISORDERS Headache For Quality Improvement Only. Not to be used for Public Reporting or Accountability Measure Description Percentage
More informationControlling Migraine Pain
Migraine Stats Controlling Migraine Pain Alan Zacharias, M.D. Associated Neurologists, Boulder Community Health 303-622-3365 Women 15% Men 5% Usually starts in 2 nd and 3 rd Decade Major Impact on days
More informationIroquois Healthcare Association (IHA) Opioid Alternative Project. Clinician Training Materials
Iroquois Healthcare Association (IHA) Opioid Alternative Project Clinician Training Materials Introduction IHA Opioid Alternative Project Clinician Toolkit Course Overview Thank you for participating
More informationAn Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California
An Overview of MOH IHS ASIAN HA MASTERS SCHOOL MARCH 24, 2013 ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California President-Elect
More informationApproach to the Workup and Management of Headache in the Emergency Department and Inpatient Settings
667 Approach to the Workup and Management of Headache in the Emergency Department and Inpatient Settings Morris Levin, MD 1 1 Division of Headache Medicine, Department of Neurology, University of California,
More informationMigraine much more than just a headache
Migraine much more than just a headache Session hosted by Teva UK Limited PUU4 11:15 12:15 UK/NHSS/18/0021b Date of Preparation: August 2018 The views expressed in this presentation are those of the speaker
More informationManagement options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM
Management options for Migraine Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM Assessment The Migraine Disability Assessment Score MIDAS Complete loss of work Partial loss of work Off
More informationPHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 5/18/17 SECTION: DRUGS LAST REVIEW DATE: 5/17/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:
ALLZITAL (butalbital and acetaminophen) 25 mg/325 mg oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationManaging Headache in Acute Medicine. Ben Lovell Consultant Physician in Acute Medicine University College London Hospital
Managing Headache in Acute Medicine Ben Lovell Consultant Physician in Acute Medicine University College London Hospital Some ED headache stats Arrive by ambulance 31% Median age 39 Worst ever headache
More informationStrategies in Migraine Care
Strategies in Migraine Care Julie L. Roth, MD Rhode Island Hospital Assistant Professor, Neurology The Warren Alpert Medical School of Brown University March 28, 2015 Financial Disclosures None. Objectives
More informationMIGRAINE ASSOCIATION OF IRELAND
MIGRAINE ASSOCIATION OF IRELAND HEADACHE IN MEN: THE FACTS This leaflet was composed by Paolo Rossi M.D., Ph.D. of the European Headache Alliance to mark European Migraine Day of Action 2014. Why a leaflet
More informationAcute Migraine Treatment. Morris Levin, MD Professor of Neurology Director, Headache Center UCSF Department of Neurology San Francisco, CA
Acute Migraine Treatment Morris Levin, MD Professor of Neurology Director, Headache Center UCSF Department of Neurology San Francisco, CA Mo Levin Disclosures Consulting Allergan Supernus Amgen Lilly Royalties
More informationHEADACHE 1 Pablo Lapuerta, M.D., and Steven Asch, M.D., M.P.H.
- 253-13. HEADACHE 1 Pablo Lapuerta, M.D., and Steven Asch, M.D., M.P.H. We identified articles on the evaluation and management of headache by conducting a MEDLINE search of English language articles
More informationCan I send this headache patient home? Dr Nicola Giffin Consultant Neurologist Bath, Nov 2017
Can I send this headache patient home? Dr Nicola Giffin Consultant Neurologist Bath, Nov 2017 SAH v benign thunderclap headaches Other pathologies not apparent on CT Severe primary headaches: management
More informationMigraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification
28 Primary Care Medicine Principles and Practice 29 October 28 Professor Peter J. Goadsby Peter.Goadsby@headache.ucsf.edu Department of Neurology Headache International Headache Society Classification
More informationAcute Migraine Treatment: What you and your family should know to help you make the best choices with your doctor
Acute Migraine Treatment: What you and your family should know to help you make the best choices with your doctor TAKE CONTROL OF YOUR MIGRAINES! ABOUT THIS PATIENT GUIDE: Migraine attacks are often debilitating
More informationÇiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE
Headache in children and adolescents Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE Dept. of Psychiatry of Childhood and Adolescence Medical University of Vienna, Vienna, Austria Impact
More informationdisease or in clients who consume alcohol on a regular basis. bilirubin
NON-OPIOID Acetaminophen(Tylenol) Therapeutic class: Analgesic, antipyretic Aspirin (ASA, Acetylsalicylic Acid) Analgesic, NSAID, antipyretic Non-Opioid Analgesics COMMON USES WHAT I NEED TO KNOW AS A
More informationRisk Factors, Clinical Course, and Barriers to Care in Adults and Pediatrics. Rebecca R. Buttaccio, PA-C Dent Neurologic Institute
Risk Factors, Clinical Course, and Barriers to Care in Adults and Pediatrics Rebecca R. Buttaccio, PA-C Dent Neurologic Institute Speaker for Avanir Disclosures Learning Objectives 1. Review the risk factors
More informationOCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA
OMED 17 OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA 29.5 Category 1-A CME credits anticipated ACOFP / AOA s 122 nd Annual Osteopathic Medical Conference & Exposition Joint Session with ACOFP, ACONP and AOAAM:
More informationSean Kelcey CCPA EM PA Selkirk Regional Health Center Selkirk, MB CAPA 2017
Sean Kelcey CCPA EM PA Selkirk Regional Health Center Selkirk, MB CAPA 2017 I HAVE NO FINANCIAL DISCLOSURES TO MENTION AND DO NOT REPRESENT ANY DRUG DEALERS, LEGAL OR OTHERWISE ANY MENTION OF BRAND NAME
More informationUPDATE IN MIGRAINE MANAGEMENT
UPDATE IN MIGRAINE MANAGEMENT Eric P. Baron, DO Cleveland Clinic Neurological Institute Center for Neurological Restoration Headache and Chronic Pain Medicine barone2@ccf.org @Neuralgroover Disclosures
More informationUnderstanding. Migraine. Amy, diagnosed in 1989, with her family.
Understanding Migraine Amy, diagnosed in 1989, with her family. What Is a Migraine? A migraine is a recurring moderate to severe headache. The pain usually occurs on one side of the head. It is typically
More informationHeadache. Section 1. Migraine headache. Clinical presentation
Section 1 Headache Migraine headache 1 Clinical presentation It is important to recognize just how significant a problem migraine headache is. It has been estimated that migraine affects 11% of the United
More informationScreening - inclusion criteria
A Date of data collection: B Time of data collection: C Ward where data is collected: 2 0 1 Y M M D D H H M M D Research assistant Code: Patient code (local): Room number: Screening - inclusion criteria
More informationPAEDIATRIC ACUTE CARE GUIDELINE. Headache. This document should be read in conjunction with this DISCLAIMER
Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should be read in conjunction
More informationRegulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.60 Subject: Migranal Nasal Spray Page: 1 of 5 Last Review Date: November 30, 2018 Migranal Nasal Spray
More informationWhat is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary
What is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary Overview Understanding the burden Commonly used terms Acute therapy What we currently have What we are going
More informationThe presenting and prescribing patterns of migraine in an Australian emergency department: A descriptive exploratory study
170 Shao et al Original Article The presenting and prescribing patterns of migraine in an Australian emergency department: A descriptive exploratory study Emily Shao 1, James Hughes 2, Rob Eley 2,3 1 Royal
More informationImproving Health, Enriching Life. Pain Management. Altru HEALTH SYSTEM
Improving Health, Enriching Life altru.org Pain Management Altru HEALTH SYSTEM There are many different causes and kinds of pain. Pain can be caused by injury, illness, sickness, disease or surgery. Treating
More informationPain Management Strategies Webinar/Teleconference
Pain Management Strategies Webinar/Teleconference Barry K. Baines, MD April 16, 2009 Objectives Describe the principles of pain management. Identify considerations in the use of opioids. Describe the benefits
More information